JS Nachnani, DG Bulchandani, A Nookala, B … - Diabetologia - Springer Abstract Aims/hypothesis Exendin-4 is a 39 amino acid agonist of the
glucagon-like peptide receptor and has been approved for treatment of type 2
diabetes. Many reports describe an increased incidence of acute ... Related articles - All 2 versions
J Khoo, CK Rayner, KL Jones, M Horowitz, 2009 - pubmedcentral.nih.gov The advent of 'incretin-based therapies' – GLP-1 agonists and
dipeptidyl-peptidase-4 inhibitors – which result in improvements in glycemic
control comparable to those with existing oral hypoglycemic agents, and ... Related articles - All 4 versions